Selective and Nonselective Serotonin Antagonists Block the Aversive Stimulus Properties of MK212 and M-chlorophenylpiperazine (mCPP) in Mice
Overview
Pharmacology
Authors
Affiliations
Serotonin(2C) (5-HT(2C)) receptors have been implicated to treat mood disorders such as depression and anxiety. In the present study, the capacities of two 5-HT(2C) agonists, MK212 and mCPP, to produce conditioned taste aversions in mice were evaluated. On two training days, Swiss-Webster male mice (19-34g) were trained to associate the flavor of a novel solution with the injection of various doses of MK212 or mCPP. On two alternate training days, mice were trained to associate a different flavored solution with an injection of saline. For testing, both flavored solutions were presented simultaneously and an avoidance of the MK212 or mCPP-paired solution indicated conditioned taste aversion. Robust conditioned taste aversions were observed to solutions paired with 1.0 or 10mg/kg MK212 or mCPP. Acquisition of conditioned taste aversions was blocked by nonselective serotonin antagonists cyproheptadine, bromo-LSD, metergoline, methysergide and mianserin. Selective 5-HT(2B/2C) antagonist SB206,553 blocked both MK212- and mCPP-induced conditioned taste aversion although selective 5-HT(2B/2C) antagonist SB200,646 only blocked mCPP-induced conditioned taste aversion. In a single-bottle procedure, MK212, bromo-LSD, and mianserin failed to alter acquisition rate of a LiCl-induced conditioned taste aversion. Taken together, these data indicate that the serotonin agonists MK212 and mCPP produce conditioned taste aversion and that these effects are mediated predominantly through 5-HT(2C) receptors.
Aminergic control of social status in crayfish agonistic encounters.
Momohara Y, Kanai A, Nagayama T PLoS One. 2013; 8(9):e74489.
PMID: 24058575 PMC: 3776855. DOI: 10.1371/journal.pone.0074489.
Walker E, Foley J Behav Pharmacol. 2010; 21(2):83-9.
PMID: 20177374 PMC: 6511452. DOI: 10.1097/FBP.0b013e328337bde7.
Brookshire B, Jones S Pharmacol Biochem Behav. 2009; 94(1):194-203.
PMID: 19698737 PMC: 2768771. DOI: 10.1016/j.pbb.2009.08.008.
Li J, Unzeitig A, Javors M, Rice K, Koek W, France C J Pharmacol Exp Ther. 2009; 331(2):671-9.
PMID: 19687292 PMC: 2775261. DOI: 10.1124/jpet.109.157560.
Dekeyne A, Millan M Psychopharmacology (Berl). 2008; 203(2):329-41.
PMID: 18709360 DOI: 10.1007/s00213-008-1259-8.